Company Overview
TENAYA THERAPEUTICS, INC.
TNYARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-91M
2025 FY
Shares Outstanding
153M
2025 FY
EPS
-0.59USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1858848
Exchange
Nasdaq
Location
US